GPT and cancer: Telomerase is present in tumor cells from over 85% of cancer types, while about 15% of them continue the telomere lengthening through homologous recombination processes collectively known as alternative lengthening of telomeres (ALT), which is not a telomerase-dependent mechanism [70,71,72].